MTD 215
Alternative Names: MTD-215Latest Information Update: 16 May 2023
Price :
$50 *
At a glance
- Originator Midatech
- Developer Biodexa Pharmaceuticals
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Unspecified